ATE143414T1 - Hauptprotein der aussenmembran von chlamydia - Google Patents

Hauptprotein der aussenmembran von chlamydia

Info

Publication number
ATE143414T1
ATE143414T1 AT86100279T AT86100279T ATE143414T1 AT E143414 T1 ATE143414 T1 AT E143414T1 AT 86100279 T AT86100279 T AT 86100279T AT 86100279 T AT86100279 T AT 86100279T AT E143414 T1 ATE143414 T1 AT E143414T1
Authority
AT
Austria
Prior art keywords
outer membrane
deposited
culture collection
type culture
chlamydia
Prior art date
Application number
AT86100279T
Other languages
English (en)
Inventor
Nina Agabian
Richard Stephens
Cho-Chou Kuo
Guy T Mullenbach
Original Assignee
Chiron Corp
Washington Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24778877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE143414(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp, Washington Res Found filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE143414T1 publication Critical patent/ATE143414T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56927Chlamydia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT86100279T 1985-01-14 1986-01-10 Hauptprotein der aussenmembran von chlamydia ATE143414T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69200185A 1985-01-14 1985-01-14

Publications (1)

Publication Number Publication Date
ATE143414T1 true ATE143414T1 (de) 1996-10-15

Family

ID=24778877

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86100279T ATE143414T1 (de) 1985-01-14 1986-01-10 Hauptprotein der aussenmembran von chlamydia

Country Status (4)

Country Link
EP (1) EP0192033B1 (de)
AT (1) ATE143414T1 (de)
CA (1) CA1341133C (de)
DE (1) DE3650571T2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI883067A7 (fi) * 1988-06-27 1989-12-28 Labsystems Oy Foerfarande foer behandling av koronarkaerlsjukdom.
IT1244706B (it) * 1991-02-07 1994-08-08 Sclavo Spa Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
WO1996007910A1 (en) * 1994-09-02 1996-03-14 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection
WO1996016178A1 (en) * 1994-11-17 1996-05-30 Maxim Pharmaceuticals, Inc. Immunogens for stimulating mucosal immunity
US6696421B2 (en) 1996-07-12 2004-02-24 University Of Manitoba DNA immunization against chlamydia infection
US6235290B1 (en) 1997-07-11 2001-05-22 University Of Manitoba DNA immunization against chlaymdia infection
ATE312920T1 (de) * 1996-07-12 2005-12-15 Dna immunisierung gegen chlamydia infektion
US6344202B1 (en) 1996-07-12 2002-02-05 University Of Manitoba DNA immunization against chlaymdia infection
US6579854B1 (en) 1996-08-14 2003-06-17 Vanderbilt University Diagnosis and management of infection caused by chlamydia
GB9621771D0 (en) 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
US6884784B1 (en) 1997-05-06 2005-04-26 Vanderbilt University Diagnosis and management of infection caused by chlamydia
US6664239B2 (en) 1997-05-06 2003-12-16 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
DE69838214T2 (de) * 1997-05-06 2008-05-08 Vanderbilt University, Nashville Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen
US6756369B2 (en) 1997-05-06 2004-06-29 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
IL121115A (en) 1997-06-19 2001-06-14 Savyon Diagnostics Ltd C. trachomatis specific peptides and their use in diagnostic assays
EP2218731A1 (de) * 1997-11-28 2010-08-18 Merck Serono Biodevelopment Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
EP1169465B1 (de) 1998-12-04 2006-03-01 University Of Manitoba Zwei-schritte-verfahren zur impfung gegen chlamydia
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6191259B1 (en) * 1999-05-19 2001-02-20 Wisconsin Alumni Research Foundation Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
US6225443B1 (en) 1999-05-19 2001-05-01 Wisconsin Alumni Research Foundation Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP3220962A4 (de) * 2014-11-21 2018-07-25 Merck Sharp & Dohme Corp. Rekombinante expression des chlamydien-momp-antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427782A (en) * 1981-03-03 1984-01-24 Caldwell Harlan D Isolation of principal outer membrane protein and antigen of Chlamydia trachomatis
ES8600404A1 (es) * 1983-05-02 1985-10-01 Enzo Biochem Inc Un metodo para detectar una secuencia seleccionada de acido nucleico en un material biologico.

Also Published As

Publication number Publication date
EP0192033A2 (de) 1986-08-27
DE3650571T2 (de) 1997-02-27
EP0192033A3 (de) 1988-05-04
EP0192033B1 (de) 1996-09-25
CA1341133C (en) 2000-11-07
DE3650571D1 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
ATE143414T1 (de) Hauptprotein der aussenmembran von chlamydia
LU91304I2 (fr) A tryn-antithrombin alfa
CA2099841A1 (en) Expression of recombinant proteins in attenuated bacteria
ATE76428T1 (de) Expression und sekretion von polypeptiden in eukaryoten unter kontrolle eines adenoviruspromotors.
ES532825A0 (es) Un metodo de sintetizar un polipeptido seleccionado
DE69535495D1 (de) Expression und exporttechnologie von proteinen als an immunoglobin gebundene fusionsproteine
FI855141A7 (fi) Rekombinantti-DNA-vektoreita, jotka kykenevät ilmaisemaan apoaequoriinia.
DE69632658D1 (de) Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
ATE109829T1 (de) Interleukin-7.
EP0161935A3 (de) Verfahren, Vektoren und transformierte Zellen für erhöhte Expression von heterologen Polypeptiden in Hefe
DE69016508D1 (de) Interleukin-7-Rezeptoren.
JPH082315B1 (de)
GB2162851B (en) Novel b-urogastrone gene, corresponding recombinant plasmids, corresponding transformants and preparations thereof and of b-urogastrone.
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
NZ334604A (en) A DNA molecule containing a baculovirus promoter operable linked to a coding sequnce for an insect-specific toxin; biological insect control agents comprising the altered baculovirus
FI841288A7 (fi) Rekombinaatti-DNA-koodaus polypeptidin ilmaisemiseksi.
AU4569285A (en) Nematode control by recombinant microorganisms
DE58908428D1 (de) Sekretormutante von Escherichia coli.
PT599971E (pt) Promotor de levedura e sua utilizacao
NO164039C (no) Fremgangsmaate for fremstilling av et antibiotisk aktivt polypeptid.
EP0077664A3 (en) Recombinant dna and coliform bacillus having genetic material for the production of staphylokinase, and the production of staphylokinase
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
ES8506194A1 (es) Polipeptido de interferon- humano
EP0187630A3 (en) Cloned streptomyces beta-galactosidase gene

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked